+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intrathecal Pumps Market by Pump Type, Therapy Area, End User, Drug Type, Reservoir Capacity - Global Forecast to 2030- Product Image
Intrathecal Pumps Market by Pump Type, Therapy Area, End User, Drug Type, Reservoir Capacity - Global Forecast to 2030- Product Image
Sale

Intrathecal Pumps Market by Pump Type, Therapy Area, End User, Drug Type, Reservoir Capacity - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666146
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Intrathecal Pumps Market grew from USD 495.22 million in 2024 to USD 540.67 million in 2025. It is expected to continue growing at a CAGR of 8.84%, reaching USD 823.30 million by 2030.

Reimagining Pain Relief With Innovative Pump Technology

Intrathecal pump therapy has emerged as a transformative solution for patients suffering from chronic pain and spasticity, offering precise drug delivery directly to the cerebrospinal fluid. By bypassing systemic circulation, these devices achieve effective pain relief at substantially lower drug dosages, thereby minimizing the risk of side effects often associated with oral or systemic administration. Over the past decade, clinicians and device manufacturers have collaborated to refine catheter designs, reservoir mechanisms, and programmable infusion parameters, yielding enhanced reliability and user convenience.

Transitioning from traditional pain management approaches, intrathecal systems now stand at the forefront of personalized therapy, enabling physicians to tailor dosing regimens based on patient response and tolerability. This paradigm shift underscores the critical role of intrathecal pumps in addressing complex pain syndromes such as cancer pain, chronic noncancer pain, and neuromuscular disorders leading to spasticity. Moreover, as healthcare providers increasingly emphasize patient-centric models, these implantable and external pump solutions are paving the way for improved quality of life, reduced hospital readmissions, and optimized resource allocation within interdisciplinary pain management programs.

Shifting Paradigms: Key Drivers Transforming Intrathecal Therapy

In recent years, the intrathecal pump sector has witnessed profound shifts driven by technological breakthroughs, evolving regulatory mandates, and changing healthcare economics. Wireless programming and telemetric monitoring now allow clinicians to remotely adjust infusion rates and monitor device performance, eliminating the need for frequent clinic visits. Smart algorithms embedded within pump controllers are detecting occlusions and flow irregularities in real time, alerting care teams to potential complications before they escalate.

On the policy front, stringent safety directives and updated device approval pathways have elevated the standard for pre-market testing and post-market surveillance, encouraging manufacturers to invest in robust clinical evidence and risk-mitigation strategies. Concurrently, the emphasis on value-based care models has pressured stakeholders to demonstrate long-term cost effectiveness by reducing hospitalization rates and opioid reliance. As a result, payers and health systems are collaborating with device innovators to establish outcome-based reimbursement frameworks that reward demonstrable patient benefits. Together, these converging trends are redefining the competitive landscape, compelling companies to differentiate through innovation, data integration, and strategic alliances.

US Tariffs 2025: Navigating New Trade Barriers in Device Supply

The United States announced comprehensive tariffs on select medical device components effective 2025, encompassing critical pump systems and accessory parts sourced internationally. Manufacturers relying on cross-border supply chains are grappling with increased import duties that translate directly into higher production costs. Consequently, device producers are recalibrating procurement strategies, exploring alternative suppliers in tariff-free zones, and evaluating localized manufacturing to mitigate cost pressures.

Healthcare providers and purchasing groups face the downstream effects of these tariffs as device acquisition costs rise. Hospitals and specialty clinics negotiating fixed-price contracts anticipate margin squeezes, prompting them to seek volume-based discounts or swap to alternative therapies where clinically feasible. Moreover, the tariffs are accelerating consolidation among mid-sized suppliers unable to absorb increased duties, further reshaping the competitive field. In response, some innovators are accelerating development of lower-cost external pump systems and refillable implantable models that require fewer imported components, ensuring continued patient access while preserving profitability across the value chain.

Deep Dive Into Market Segments Revealing Growth Opportunities

Analyzing the intrathecal pump market through the lens of pump type reveals two primary categories: external pumps and implantable pumps, the latter featuring refillable reservoirs that reduce the frequency of surgical interventions. Within the domain of therapy areas, patient populations split between pain management and spasticity management. Pain management further segments into cancer pain and chronic noncancer pain, reflecting the nuanced dosing requirements and risk profiles of these patient cohorts. Spasticity management subdivides into cerebral palsy, multiple sclerosis, and spinal cord injury, each presenting unique neuromuscular challenges and delivery considerations.

End users encompass ambulatory surgical centers, hospitals, and specialty clinics that administer intrathecal therapies across diverse care settings. Drug type analysis distinguishes non-opioid medications such as baclofen and ziconotide from opioid agents like fentanyl and morphine, highlighting the need to balance efficacy with safety and regulatory compliance. Reservoir capacity adds another dimension of granularity, categorizing devices as less than ten milliliter, ten to twenty milliliter, and greater than twenty milliliter, each suited to varying dosing regimens and refill intervals. Together, these segmentation insights offer a multifaceted view of market opportunities and inform targeted development, marketing, and distribution strategies.

Region-Specific Dynamics Shaping Intrathecal Device Adoption

In the Americas, robust reimbursement frameworks and a high prevalence of chronic pain disorders drive advanced intrathecal pump adoption. Leading healthcare institutions partner with innovators to conduct real-world studies, further validating cost-effectiveness and patient outcomes. Meanwhile, reimbursement authorities are increasingly receptive to evidence of reduced opioid dependency, streamlining approval pathways for novel systems.

Across Europe, Middle East & Africa, market dynamics vary widely. Western European countries with centralized health technology assessment bodies demand comprehensive comparative data, prompting manufacturers to invest in region-specific clinical trials. In contrast, emerging markets in the Middle East & Africa exhibit growing demand but face budgetary constraints and fragmented distribution networks, challenging stakeholders to devise tailored pricing and access models.

The Asia-Pacific region presents a spectrum of opportunities and obstacles. Countries with established healthcare infrastructure, such as Japan and Australia, are early adopters of next-generation pump platforms, while rapidly expanding markets in China and India emphasize cost containment. Local regulatory reforms aimed at accelerating device approvals and incentivizing domestic manufacturing are reshaping competitive dynamics, compelling global companies to forge joint ventures and technology transfer agreements to secure market share.

Competitive Landscape: Leading Players Steering Market Evolution

The competitive landscape in the intrathecal pump domain is anchored by a handful of leading medical device companies distinguished by comprehensive product portfolios and strong clinical footprints. One major player continues to refine its programmable implantable systems, leveraging decades of neuromodulation expertise and a global service network to support training and post-market surveillance. Another innovator has gained traction with its compact external pump, emphasizing remote monitoring capabilities and patient adherence features that resonate with value-based care models.

A strategic entrant from the pharmaceutical sector has introduced proprietary drug-device combinations, securing partnerships with leading research centers to fast-track combination therapy approvals. Concurrently, a specialty device manufacturer focuses on refillable reservoir enhancements and modular catheter interfaces, catering to complex spasticity cases. Smaller niche players differentiate through customizable software platforms and digital health integrations, collaborating with telehealth providers to deliver end-to-end therapy management. Observing these varied approaches underscores the imperative for sustained R&D investment and strategic alliances to maintain competitive leadership.

Strategic Imperatives for Stakeholders in a Dynamic Market

Industry leaders should intensify investment in next-generation pump architectures that integrate telemetric monitoring, predictive maintenance algorithms, and patient engagement features. Partnering with digital health firms will enhance care continuity and strengthen value propositions for payers focused on long-term outcomes. Concurrently, forging collaborations with reimbursement authorities and clinical consortia can secure inclusion in outcome-based payment models, ensuring predictable revenue streams while demonstrating cost offsets through reduced hospital readmissions.

Geographic expansion strategies must balance regulatory compliance with local market sensitivities. Establishing regional manufacturing hubs or technology transfer partnerships will mitigate tariff impacts and accelerate time to market. In parallel, customizing device designs to accommodate varied reservoir capacities and therapy regimens will address unmet needs in both high-income and emerging economies. Finally, cultivating thought leadership through strategic sponsorship of real-world evidence studies will reinforce clinical differentiation, driving broader adoption among pain specialists, neurologists, and rehabilitation experts.

Robust Research Framework Underpinning Our Analysis

This analysis is grounded in a rigorous research framework combining extensive secondary research with targeted primary interviews. The secondary phase encompassed peer-reviewed journals, regulatory filings, patent databases, and industry conference proceedings to capture technological advancements and market trends. Complementing this, primary insights were obtained through structured interviews with clinicians, procurement executives, regulatory experts, and device manufacturers, ensuring nuanced perspectives on clinical adoption, reimbursement challenges, and competitive strategies.

Data triangulation validated key findings by cross-referencing multiple data sources and reconciling discrepancies through follow-up engagements. We employed thematic analysis to identify disruptive innovations, regulatory shifts, and market barriers. Qualitative insights were quantified using proprietary scoring models to assess competitive positioning, technology readiness levels, and regional market attractiveness. This robust methodology ensures that conclusions and recommendations reflect the latest industry developments and provide a reliable foundation for strategic decision-making.

Final Reflections on the Intrathecal Pump Landscape

Intrathecal pump therapy stands at the cusp of a new era, driven by converging forces of technological innovation, evolving reimbursement paradigms, and shifting global trade dynamics. As external and implantable refillable systems become more sophisticated, stakeholders must navigate the complex interplay of regulatory requirements, supply chain pressures, and emerging patient-centric care models. The segmentation insights across pump type, therapy area, end user, drug type, and reservoir capacity underscore the market’s multifaceted nature and highlight targeted growth vectors.

Regional variations from the Americas to Europe, the Middle East, Africa, and Asia-Pacific further illustrate the necessity for customized strategies that address local clinical needs, regulatory landscapes, and economic realities. Major competitors are doubling down on R&D, strategic partnerships, and digital integrations, setting a high bar for differentiation. Against this backdrop, industry leaders who proactively adapt through innovation, collaboration, and evidence-based value demonstration will secure enduring market leadership. The collective findings affirm that the future of intrathecal therapy lies in seamless device ecosystems, data-driven clinical insights, and patient-centered models of care.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Pump Type
    • External Pumps
    • Implantable Pumps
      • Refillable Pumps
  • Therapy Area
    • Pain Management
      • Cancer Pain
      • Chronic Noncancer Pain
    • Spasticity Management
      • Cerebral Palsy
      • Multiple Sclerosis
      • Spinal Cord Injury
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Drug Type
    • Non Opioid
      • Baclofen
      • Ziconotide
    • Opioid
      • Fentanyl
      • Morphine
  • Reservoir Capacity
    • Greater Than Twenty Milliliter
    • Less Than Ten Milliliter
    • Ten To Twenty Milliliter
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • Flowonix Medical, Inc.
  • Tricumed Medizintechnik
  • Teleflex
  • Johnson & Johnson

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Intrathecal Pumps Market, by Pump Type
8.1. Introduction
8.2. External Pumps
8.3. Implantable Pumps
8.3.1. Refillable Pumps
9. Intrathecal Pumps Market, by Therapy Area
9.1. Introduction
9.2. Pain Management
9.2.1. Cancer Pain
9.2.2. Chronic Noncancer Pain
9.3. Spasticity Management
9.3.1. Cerebral Palsy
9.3.2. Multiple Sclerosis
9.3.3. Spinal Cord Injury
10. Intrathecal Pumps Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Intrathecal Pumps Market, by Drug Type
11.1. Introduction
11.2. Non Opioid
11.2.1. Baclofen
11.2.2. Ziconotide
11.3. Opioid
11.3.1. Fentanyl
11.3.2. Morphine
12. Intrathecal Pumps Market, by Reservoir Capacity
12.1. Introduction
12.2. Greater Than Twenty Milliliter
12.3. Less Than Ten Milliliter
12.4. Ten To Twenty Milliliter
13. Americas Intrathecal Pumps Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Intrathecal Pumps Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Intrathecal Pumps Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Medtronic plc
16.3.2. Flowonix Medical, Inc.
16.3.3. Tricumed Medizintechnik
16.3.4. Teleflex
16.3.5. Johnson & Johnson
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INTRATHECAL PUMPS MARKET MULTI-CURRENCY
FIGURE 2. INTRATHECAL PUMPS MARKET MULTI-LANGUAGE
FIGURE 3. INTRATHECAL PUMPS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL INTRATHECAL PUMPS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INTRATHECAL PUMPS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INTRATHECAL PUMPS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. INTRATHECAL PUMPS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INTRATHECAL PUMPS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY EXTERNAL PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY REFILLABLE PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY CHRONIC NONCANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY CEREBRAL PALSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY SPINAL CORD INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY BACLOFEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY ZICONOTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY FENTANYL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY MORPHINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY GREATER THAN TWENTY MILLILITER, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY LESS THAN TEN MILLILITER, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY TEN TO TWENTY MILLILITER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. CANADA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 62. CANADA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 63. CANADA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 64. CANADA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 65. CANADA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. CANADA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 68. CANADA INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 69. CANADA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 70. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 73. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 74. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 75. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 78. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 79. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 121. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 124. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 125. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 126. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 129. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 130. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 131. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 132. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 133. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 134. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 135. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 136. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 139. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 140. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 151. ITALY INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 152. ITALY INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 153. ITALY INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 154. ITALY INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 155. ITALY INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 156. ITALY INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ITALY INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 159. ITALY INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 160. ITALY INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 161. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 162. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 163. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 164. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 165. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 166. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 169. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 170. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 201. DENMARK INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 202. DENMARK INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 203. DENMARK INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 204. DENMARK INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 205. DENMARK INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 206. DENMARK INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. DENMARK INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 209. DENMARK INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 210. DENMARK INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 221. QATAR INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 222. QATAR INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 223. QATAR INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 224. QATAR INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 225. QATAR INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 226. QATAR INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. QATAR INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 228. QATAR INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 229. QATAR INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 230. QATAR INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 231. FINLAND INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 232. FINLAND INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 233. FINLAND INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 234. FINLAND INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 235. FINLAND INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 236. FINLAND INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. FINLAND INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 238. FINLAND INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 239. FINLAND INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 240. FINLAND INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 241. SWEDEN INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 261. EGYPT INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 262. EGYPT INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 263. EGYPT INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 264. EGYPT INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 265. EGYPT INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 266. EGYPT INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. EGYPT INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 268. EGYPT INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 269. EGYPT INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 270. EGYPT INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 271. TURKEY INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 272. TURKEY INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 273. TURKEY INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 274. TURKEY INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 275. TURKEY INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 276. TURKEY INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. TURKEY INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 278. TURKEY INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 279. TURKEY INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 280. TURKEY INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 291. NORWAY INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 292. NORWAY INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 293. NORWAY INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 294. NORWAY INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 295. NORWAY INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 296. NORWAY INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. NORWAY INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 298. NORWAY INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 299. NORWAY INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 300. NORWAY INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 301. POLAND INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 302. POLAND INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 303. POLAND INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 304. POLAND INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 305. POLAND INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 306. POLAND INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. POLAND INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 308. POLAND INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 309. POLAND INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 310. POLAND INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 311. SWITZERLAND INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 312. SWITZERLAND INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 313. SWITZERLAND INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 314. SWITZERLAND INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 315. SWITZERLAND INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 316. SWITZERLAND INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 321. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 322. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 323. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 324. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 325. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 326. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 332. CHINA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 333. CHINA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 334. CHINA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 335. CHINA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 336. CHINA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 337. CHINA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 338. CHINA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 339. CHINA INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 340. CHINA INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 341. CHINA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 342. INDIA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2030 (USD MILLION)
TABLE 343. INDIA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2030 (USD MILLION)
TABLE 344. INDIA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 345. INDIA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 346. INDIA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 347. INDIA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 348. INDIA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 349. INDIA INTRATHECAL PUMPS MARKET SIZE, BY NON OPIOID, 2018-2030 (USD MILLION)
TABLE 350. INDIA INTRATHECAL PUMPS MARKET SIZE, BY OPIOID, 2018-2030 (USD MILLION)
TABLE 351. INDIA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2030 (USD MILLION)
TABLE 352. JAPAN INTRATHECAL PUMPS MARKET SIZE, BY PUM

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Intrathecal Pumps market report include:
  • Medtronic plc
  • Flowonix Medical, Inc.
  • Tricumed Medizintechnik
  • Teleflex
  • Johnson & Johnson

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 540.67 Million
Forecasted Market Value ( USD ) by 2030 $ 823.3 Million
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

Intrathecal Pumps Market Size, Share & Trends Analysis Report By Type (Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide), By Application (Pain, Spasticity), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Intrathecal Pumps Market Size, Share & Trends Analysis Report By Type (Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide), By Application (Pain, Spasticity), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 130 Pages
  • Global
From
Intrathecal Pumps - Global Strategic Business Report - Product Image

Intrathecal Pumps - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Spinal Needle Market by Product Type, Application, End User, Gauge, Material - Global Forecast to 2030 - Product Image

Spinal Needle Market by Product Type, Application, End User, Gauge, Material - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Implantable Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Implantable Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Implantable Infusion Pumps Market Report 2025 - Product Image

Implantable Infusion Pumps Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Intrathecal Pump Market

The Intrathecal Pump market is a subset of the Infusions and Injectables market. Intrathecal pumps are medical devices used to deliver medications directly into the cerebrospinal fluid of the spinal cord. This method of drug delivery is used to treat chronic pain, spasticity, and other neurological disorders. Intrathecal pumps are surgically implanted and programmed to deliver a continuous, low-dose of medication over a long period of time. This method of drug delivery is advantageous because it allows for a more precise dosage and fewer side effects than traditional oral medications. The Intrathecal Pump market is highly competitive, with several major players. Some of the companies in the market include Medtronic, Baxter, Smiths Medical, and B. Braun. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.